OgGen (NASDAQ:OPGN) prices its public offering of 3,692,307 units at $3.25 per unit. Each unit consists of one share of common stock and one five-year warrant to purchase 1/2 of a share of common at $3.25. Closing date is February 6.
Net proceeds will fund R&D, the continued development and manufacturing of its Acuitas AMR Gene Panels, acquisitions of products and technologies, capex, working capital and general corporate purposes.
Yesterday's close was $3.65. Shares are down 18% premarket on light volume.
Subscribe for full text news in your inbox